NY Times op-ed about "the latest salvo in a continuing battle between the publishers of biomedical research journals like Cell, Science and The New England Journal of Medicine, which are seeking to protect a valuable franchise, and researchers, librarians and patient advocacy groups seeking to provide open access to publicly funded research"
Friday, January 13, 2012
Subscribe to:
Post Comments (Atom)
Posts
0 comments:
Post a Comment